Department of Otolaryngology, University of Arizona, Tucson, Ariz; Asthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz.
Asthma and Airway Disease Research Center, University of Arizona, Tucson, Ariz.
J Allergy Clin Immunol. 2018 Apr;141(4):1291-1297.e2. doi: 10.1016/j.jaci.2017.11.052. Epub 2018 Feb 21.
Chronic sinusitis is a commonly diagnosed condition in adults who frequently present with late-stage disease and irreversible changes to the sinus mucosa. Understanding the natural history of chronic sinusitis is critical in developing therapies designed to prevent or slow the progression of disease.
We sought to determine early life risk factors for adult sinusitis in a longitudinal cohort study (Tucson Children's Respiratory Study).
Physician-diagnosed sinusitis was reported at age 6. Adult sinusitis between 22 and 32 years was defined as self-reported sinusitis plus physician-ordered sinus radiologic films. Atopy was assessed by skin prick test. Individuals were grouped into 4 phenotypes: no sinusitis (n = 621), transient childhood sinusitis only (n = 57), late-onset adult sinusitis only (n = 68), and early onset chronic sinusitis (childhood and adult sinusitis, n = 26).
Sinusitis was present in 10.8% of children and 12.2% of adults. Childhood sinusitis was the strongest independent risk factor for adult sinusitis (odds ratio = 4.2; 95% CI: 2.5-7.1; P < .0001; n = 772). Early onset chronic sinusitis was associated with increased serum IgE levels as early as at 9 months of age, atopy (assessed by skin prick test reactivity), childhood eczema and allergic rhinitis, frequent childhood colds, maternal asthma, and with increased prevalence of concurrent asthma. No association was found between late-onset adult sinusitis and any of the early life risk factors studied.
We identified an early onset chronic sinusitis phenotype associated with a predisposition to viral infections/colds in early life, allergies, and asthma. Elucidation of the molecular mechanisms for this phenotype may lead to future therapies to prevent the progression of the disease into adult sinusitis.
慢性鼻窦炎是成年人中常见的诊断病症,他们经常出现晚期疾病和鼻窦黏膜不可逆的变化。了解慢性鼻窦炎的自然史对于开发旨在预防或减缓疾病进展的治疗方法至关重要。
我们旨在通过纵向队列研究(图森儿童呼吸研究)确定成人鼻窦炎的早期生命危险因素。
在 6 岁时报告经医生诊断的鼻窦炎。22 至 32 岁之间的成人鼻窦炎定义为自我报告的鼻窦炎加上医生开的鼻窦射线照片。过敏症通过皮肤点刺试验评估。个体分为 4 种表型:无鼻窦炎(n=621)、仅短暂儿童期鼻窦炎(n=57)、仅迟发性成人鼻窦炎(n=68)和早发性慢性鼻窦炎(儿童期和成人鼻窦炎,n=26)。
儿童中有 10.8%和成人中有 12.2%患有鼻窦炎。儿童期鼻窦炎是成人鼻窦炎的最强独立危险因素(优势比=4.2;95%CI:2.5-7.1;P<.0001;n=772)。早发性慢性鼻窦炎早在 9 个月大时就与血清 IgE 水平升高、过敏(通过皮肤点刺试验反应性评估)、儿童期湿疹和过敏性鼻炎、频繁的儿童期感冒、母亲哮喘以及同时患有哮喘的患病率增加有关。迟发性成人鼻窦炎与研究的任何早期生命危险因素均无关联。
我们确定了一种早发性慢性鼻窦炎表型,与早期生命中的病毒感染/感冒、过敏和哮喘易感性有关。阐明这种表型的分子机制可能会导致未来的治疗方法来预防疾病进展为成人鼻窦炎。